In the BioHarmony Drug Report Database

"Preview" Icon

Escitalopram

Lexapro (escitalopram) is a small molecule pharmaceutical. Escitalopram was first approved as Lexapro on 2002-08-14. It is used to treat major depressive disorder in the USA. The pharmaceutical is active against sodium-dependent serotonin transporter. Lexapro’s patent is valid until 2022-08-12 (FDA).

 

Trade Name

 

Lexapro
 

Common Name

 

escitalopram
 

ChEMBL ID

 

CHEMBL1508
 

Indication

 

major depressive disorder
 

Drug Class

 

Selective serotonin reuptake inhibitor (SSRI)

Image (chem structure or protein)

Escitalopram structure rendering